Lasowski Juergen 4
4 · ONYX PHARMACEUTICALS INC · Filed Apr 3, 2013
Insider Transaction Report
Form 4
Lasowski Juergen
SVP, Corporate Development
Transactions
- Sale
Common Stock
2013-04-01$86.14/sh−776$66,845→ 38,140 total - Sale
Common Stock
2013-04-01$86.14/sh−1,164$100,267→ 36,265 total - Sale
Common Stock
2013-04-01$86.13/sh−711$61,238→ 37,429 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]Shares sold pursuant to a 10b5-1 arrangement.